Founded in 2022, SiBio is a pioneering startup developing Al-powered wearablesystems to decode the body's hidden signals. We believe everyone should have thepower to understand their metabolic health, and in 2023, we made history bylaunching the world's first Continuous Ketone Monitoring (CKM) system.
Three Underlying Capability Platforms
Hybrid IC Design
Based on this platform, SiBionics has the IC design capabilities, and can design implantable chips with strong stability, high accuracy and convenient transmission to achieve low power consumption and smaller size of products.
Active Implantable Devices
Active implantable process includes MEMS, airtight packaging, fine processing/assembly, precision injection molding, etc., which fully guarantees the airtightness, stability and reliability of products in the implanted environment.
AI and Medical Big Data
Established the R&D and commercialization processes from scientific research to transformation of academic achievements, and then to market-oriented applications, as well as corresponding verification, confirmation and evaluation mechanisms.